Dexamethasone treatment has no effect on the formation of pneumococcal antibodies during community-acquired pneumonia

Suzan P van Mens, Sabine C A Meijvis, Jan C Grutters, Bart J M Vlaminckx, Willem J W Bos, Ger T Rijkers

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

In this study, the effect of dexamethasone on the formation of pneumococcal antibodies during community-acquired pneumonia (CAP) was investigated. No differences between CAP patients receiving dexamethasone as additional therapy and patients receiving a placebo were found with respect to immune response rates and mean baseline and convalescent-phase antibody concentrations.

Original languageEnglish
Pages (from-to)811-813
Number of pages3
JournalClinical and Vaccine Immunology
Volume19
Issue number5
DOIs
Publication statusPublished - 2012

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Bacterial
  • Antineoplastic Agents
  • Community-Acquired Infections
  • Dexamethasone
  • Double-Blind Method
  • Female
  • Humans
  • Male
  • Middle Aged
  • Placebos
  • Pneumonia, Pneumococcal
  • Journal Article
  • Randomized Controlled Trial

Fingerprint

Dive into the research topics of 'Dexamethasone treatment has no effect on the formation of pneumococcal antibodies during community-acquired pneumonia'. Together they form a unique fingerprint.

Cite this